Dementia with Lewy bodies (DLB), the second most common type of dementia, requires a multifactorial approach to reduce symptoms.

The FDA cleared the use of the first approved blood test that can help diagnose Alzheimer’s disease. Learn more from U of U ...

The structured intervention benefit was consistent for APOE ε4 carriers and noncarriers but seemed greater for adults with lower vs higher baseline cognition.